Code | CSB-MP026137HU |
Abbreviation | Recombinant Human WNT4 protein |
MSDS | |
Size | $440 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
To make this Recombinant Human WNT4 protein, the WNT4 gene was isolated at first and cloned into an expression vector. CUSABIO has built a mature recombinant protein platform. This Recombinant Human WNT4 protein was developed in the platform. It was expressed in Mammalian cell at the region of 23-351aa of the Human WNT4 protein. C-terminal hFc tag was fused with the expression vector for affinity and purification purposes. The purity is 85%+ determined by SDS-PAGE.
WNT4 is one of the most extensively studied prototypical ligands of the Wnt family and is known to play a key role in the developmental process, such as wound healing, acute kidney injury, and angiogenesis. Previous studies have demonstrated that angiogenesis could be enhanced by the WNT4/β-catenin pathway in Human umbilical cord mesenchymal stem cells. As a member of Wnt family, WNT4 may play a role in CRC through the β-catenindependent pathway. Therefore, it would be interesting to elucidate whether WNT4 can promote the progression of CRC via promoting epithelial-tomesenchymal transition of CRC cells, activating CAFs and enhancing angiogenesis through the β-catenin-dependent pathway. Despite these observed critical roles of WNT4 in both normal and malignant tissues, WNT4 signaling is crudely understood due to varied context-dependent functions. WNT4 has been shown to regulate either β-catenin-dependent or β-cateninindependent signaling and can either activate or suppress signaling. As such, WNT4 has been described as a “problem child” among WNT proteins. So, one of the goals of WNT4 study is to clarify the signaling pathway of WNT4. In addition, recent reports suggest that the abnormality of WNT4 signaling is involved in various cancers and ovary, kidney, bone, and metabolic disorders.There are currently no reviews for this product.